More than one lesion — the hardest configuration, and a common one
Multiple lesions, kissing lesions, lesions in both compartments. What the long-term literature actually shows, why the two location programs collide for a both-compartments reader, and what this site does about it.
One knee, more than one lesion — sometimes in one compartment, sometimes in both, sometimes facing each other across the joint (“kissing” lesions, where the two damaged surfaces articulate against each other). It is the hardest configuration this operation treats, and the one the cell-therapy techniques are specifically indicated for: unlike a plug of transplanted bone, cultured chondrocytes can be laid into several defects in one operation.
It is also common in exactly the population reading this site. The long patellofemoral series are full of multiple and kissing lesions, and a knee bad enough to reach a two-stage cell operation is rarely a knee with one tidy defect.
In the five-year patellofemoral series the whole cohort stayed well above where it started, but it did not hold flat: mean IKDC ran 46.1 before surgery to 77.1 at two years and back to 70.4 at five. Patients with patellar and multiple lesions were the ones who declined between years two and five — the window after supervised rehabilitation ends.E48
That decline finding is the single most actionable sentence in the multifocal literature. Years two to five are precisely when supervised rehabilitation has ended and most people stop training — and quadriceps strength is the variable repeatedly associated with long-term outcome. It is the evidence-based argument for treating this as a long-horizon program rather than a discharge-and-forget one.
At 12.6 years — the longest patellofemoral horizon in print — 72% of patients were better or unchanged and 93% said they would have the operation again, with good results preserved even in multiple and kissing lesions, though patients without kissing lesions had the better prognosis.E49
Read together: multifocal disease does worse than an isolated femoral condyle lesion, carries more reoperations, and still overwhelmingly clears the bar patients actually care about — being glad they did it. Good but lower, not good versus hopeless.
The two locations' rehabilitation programs protect opposite things: the tibiofemoral protocols restrict weight-bearing while allowing motion, and the patellofemoral consensus allows immediate weight in a locked brace while restricting flexion under load.E5E4
A reader with grafts in both compartments inherits both sets of restrictions at once, and no study says which one governs where they collide. The combined mode exists for exactly this: it shows both programs, marks every point where they disagree, and resolves a disagreement only where this site has written out its reasoning — labelled as the author's inference, never presented as studied.
No rehabilitation protocol of any kind addresses a knee with grafts in both compartments at once. The weight-bearing trials enrolled femoral condyle lesions; the patellofemoral guidance is consensus and surveyed practice; nothing published describes a patient carrying both. Where the two programs disagree, nothing published says which restriction governs — so this site marks the disagreement and leaves it to you and your surgeon rather than resolving it for you.
Bring your operative report to the first PT session and make sure the plan addresses every lesion, not the largest one. If your surfaces kiss, ask specifically how loaded flexion is being staged, because that is where two treated surfaces press on each other.
Plan for years, not months. The decline window in the multifocal data opens when supervised rehab closes — the strength work that ends your formal program is the start of the maintenance program, not the end of the story.
Grafts in both compartments? The combined mode marks every disagreement between the two programs, on every stage and program page — choose “Both compartments” at the lesion question, changeable any time from the bar above the gated pages.
Last reviewed 2026-08-15.